Viewing Study NCT00299702


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-01-28 @ 7:48 PM
Study NCT ID: NCT00299702
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2006-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
Sponsor:
Organization: